Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orthofix International NV (NASDAQ:OFIX)

43.34
Delayed Data
As of May 03
 -0.56 / -1.28%
Today’s Change
31.30
Today|||52-Week Range
44.41
+10.53%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$800.3M

Company Description

Orthofix International NV engages in the research, development, and market of orthopedic solutions. It operates through the following segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The BioStim segment produces and sells devices for bone fusion enhancement in cervical and lumbar spine through the pulsed electromagnetic technology. The Biologics segment includes regenerative products. The Extremity Fixation segment manufactures and distributes orthopedic products for fracture repair, deformity correction, and bone reconstruction. The Spine Fixation segment develops and sells implant products for spine surgeries. The company was founded on October 19, 1987 and is headquartered in Willemstad, the Netherlands.

Contact Information

Orthofix International NV
7 Abraham de Veerstraat
Willemstad Curacao --
P:3159994658525
Investor Relations:
(214) 937-2924

Employees

Shareholders

Other institutional62.70%
Mutual fund holders35.39%
Individual stakeholders16.73%

Top Executives

Bradley R. MasonPresident, Chief Executive Officer & Director
Douglas C. RiceChief Financial & Accounting Officer
James T. RyabyChief Scientific Officer
Jill MasonChief Compliance Officer
Jeffrey Michael SchummSecretary, Chief Administrative Officer & SVP